Your browser doesn't support javascript.
loading
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Day, Michaela J; Jacobsson, Susanne; Spiteri, Gianfranco; Kulishev, Carina; Sajedi, Noshin; Woodford, Neil; Blumel, Benjamin; van der Werf, Marieke J; Amato-Gauci, Andrew J; Unemo, Magnus; Cole, Michelle J.
  • Day MJ; UK Health Security Agency, London, UK. Michaela.Day@phe.gov.uk.
  • Jacobsson S; WHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden.
  • Spiteri G; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Kulishev C; UK Health Security Agency, London, UK.
  • Sajedi N; UK Health Security Agency, London, UK.
  • Woodford N; UK Health Security Agency, London, UK.
  • Blumel B; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • van der Werf MJ; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Amato-Gauci AJ; European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Unemo M; WHO Collaborating Centre for Gonorrhoea and Other STIs, Örebro University, Örebro, Sweden.
  • Cole MJ; University College London (UCL), London, UK.
BMC Infect Dis ; 22(1): 524, 2022 Jun 07.
Article en En | MEDLINE | ID: mdl-35672671
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gonorrea / Faringitis / Minorías Sexuales y de Género / Antiinfecciosos Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Gonorrea / Faringitis / Minorías Sexuales y de Género / Antiinfecciosos Límite: Female / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article